The expression of type IV collagen α6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 15, Issue 2, 2008, Pages 555-565

  Baba, Yoshifumi ^a,b   Iyama, Ken Ichi ^a   Ikeda, Koei ^b   Ishikawa, Shinji ^b   Hayashi, Naoko ^b   Miyanari, Nobutomo ^b   Sado, Yoshikazu ^c   Ninomiya, Yoshifumi ^d   Baba, Hideo ^b  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Shigei Medical Research Institute   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Basement membrane; Esophageal cancer; Short interfering RNA; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; COL4A5 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; DISEASE FREE SURVIVAL; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STAINING; AGED; CANCER INVASION; ESOPHAGUS TUMOR; FEMALE; MALE; METABOLISM; MICRODISSECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; COLLAGEN TYPE IV; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 40649104606     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9592-4     Document Type: Article

References (39)

1. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-49
2. Rohrbach DH, Timpl R. Molecular and cellular aspects of basement membrane. San Diego: Academic Press, 1993;1-437
3. Kalluri R. Basement membrane: Structure, assembly and role in tumor angiogenesis. Nat Rev Cancer 2003;3:422-33
4. Blood CH, Zetter BR. Tumor interactions with the vasculatures: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990;1032:89-118
5. Solomon E, Hall V, Kurkinen M. The human α2(IV) collagen gene, COL4A2 is systemic with the α1(IV) gene, COL4A1, on chromosome 13. Ann Hum Genet 1987;51:125-7
6. Mariyama M, Zheng K, Yang-Feng TL, Reeders ST: Colonization of the genes for the α3(IV) and α4(IV) chains of the type IV collagen to chromosome 2 bands q35-q37. Genomics 1992;13:809-13
7. Sugimoto M, Oohashi T, Ninomia Y. The genes COL4A5 and COL4A6, coding for the basement membrane collagen chains α5(IV) and α6(IV), are located head-to-head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Proc Natl Acad Sci USA 1994;91:11679-83
8. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989;180:487-502
9. Sado Y, Kagawa M, Naito I, et al. Organization and expression of basement membrane collagen IVgenes and their roles in human disorders. J Biochem 1998;123:767-76
10. Mariyama M, Leinonen A, Mochizuki T, Tryggvan K, Reeders ST. Complete primary structure of the human α3(IV) collagen chain. Coexpression of the α3(IV) and α4(IV) collagen chains in human tissues. J Biol Chem 1994;269:23013-7
11. Ninomiya Y, Kagawa M, Iyama K, et al. Differential expression of two basement membrane collagen genes, COL4A5 and COL4A6, demonstrating by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 1995;130:1219-29
12. Simoneau A, Herring-Gillam FE, Vachon PH, et al. Identification, distribution, and tissue origin of the α5(IV) and α6(IV) collagen chains in the developing human intestine. Dev Dyn 1998;212:437-47
13. Seki T, Naito I, Oohashi T, Sado Y, Ninomiya Y. Differential expression of type IV collagen isoforms, α5(IV) and α6(IV) chains, in the basement membranes surrounding smooth muscle cells. Histochem Cell Biol 1990;110:359-66
14. Kiyofuji MA, Iyama K, Kitaoka M, Sado Y, Ninomiya Y, Ueda S. Quantitative analysis of type IV collagen alpha chains in the basement membrane of human urogenital epithelium. Histochem J 2002;34:479-86
15. Tanaka K, Iyama K, Kitaoka M, et al. Differential expression of α1(IV), α2(IV), α5(IV) and α6(IV) collagen chains in the basement membrane of basal cell carcinoma. Histochem J 1997;29:563-70
16. Nakano S, Iyama K, Ogawa M, Yoshioka H, Sado Y, Oohashi T, Ninomiya Y. Differential tissular expression and localization of type IV collagen α1(IV), α2(IV), α5(IV) and α6(IV) chains and their mRNA in normal breast and in benign and malignant breast tumors. Lab Invest 1999;79:281-92
17. Nakano KY, Iyama K, Mori T, et al. Loss of alveolar basement membrane type IV collagen α3, α4 and α5(IV) chains in bronchioloalveolar carcinoma of the lung. J Pathol 2001;194:420-7
18. Misumi S, Iyama K, Honda Y, et al. Differential expression of basement membrane type IV collagen α1, α2, α5 and α6 chains among the histological subtypes of adenoid cystic carcinoma. Virchow Arch 2004;445:54-62
19. Hiki Y, Iyama K, Tsuruta J, et al. Differential distribution of basement membrane type IV collagen α1, α2, α5 and α6 chains in colorectal epithelial tumors. Pathol Int. 2004;52:224-33
20. Ikeda K, Iyama K, Ishikawa S, et al. Loss of expression of Type IV collagen α5 and α6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol 2006;168:856-65
21. Oka Y, Naito I, Manabe K, et al. Distribution of collagen type IV α1-α6 chains in human normal colorectum and colorectal cancer demonstrated by immunofluorescence staining using chain-specific epitope defined monoclonal antibodies. J Gastroenterol Hepatol 2002;17:980-6
22. Martinella-Catusse C, Polette M, Noel A, et al. Downregulation of MT1-MMP expression by the α3 chain pf type IV collagen inhibits bronchial tumor cell line invasion. Lab Invest 2001;81:167-75
23. Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC. In vivo overexpression of tumostatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res 2004;301:251-65
24. He GA, Luo JX, Zhang TY, Hu ZS, Wang FY. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem Biophys Res Commun 2004;318:354-60
25. Petitclerc E, Boutaud A, Prestayko A, et al. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000;275:8051-61
26. Maeshima Y, Colorado PC, Torre A, et al. Distinct antitumor properties of a type IV collagen derived from basement membrane. J Biol Chem 2000;275:21340-8
27. Kamphaus GD, Colorado PC, Panka DJ, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000;275:1209-15
28. Sobin LH, Wittekind CH. TNM classification of malignant tumors, 6th ed. New York: Wiley 2002
29. Hamilton SR, Aaltonen LA. World Health Organization classification of tumours. Tumours of the Digestive System. Lyon: IARC Press, 2000
30. Sado Y, Kagawa M, Kishiro Y, et al. Establishment by the rat lymph mode method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen. Histochem Cell Biol1995;104:267-75
31. Kihara AH, Moriscot AS, Ferreira PJ, Hamassaki DM. Protecting RNA in fixed tissue: An alternative method for LCM users. J Neurosci Methods 2005;148:103-7
32. Strenlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516
33. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seike M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994;370:61-5
34. Ohashi K, Nemoto T, Nakamura K, Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1 -matrix metalloproteinase in esophageal squamous cell carcinoma. Cancer 2000;88:2201-9
35. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN. Matrix metalloproteinase expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005;100:1835-43
36. Tamamura R, Nagatsuka H, Siar CH, et al. Differential expression of basement membrane collagen-IV α1 to α6 chains during oral carcinogenesis. Virchow Arch 2006;449:358-66
37. Robey-Cafferty SS, el-Naggar AK, Sahin AA, Bruner JM, Ro JY, Clearly KR. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol 1991;95:844-89
38. Edwards JM, Hillier VF, Lawson RA, Moussalli H, Hasleton PS. Squamous carcinoma of the oesophagus: histological criteria and their prognostic significance. Br J Cancer 1989:59:429-33
39. Khan OA, Alexiou C, Soomro I, Duffy JP, Morgan WE, Beggs FD. Pathological determinants of survival in node-negative oesophageal cancer. Br J Surg 2004:91:1586-91